Association of Self-Reported Walking Pace With Cancer Incidence and Mortality: The Women's Health Accelerometry Collaboration.
1/5 보강
[BACKGROUND] While the health benefits of walking are well-established, it is not clear if walking pace is associated with cancer-related outcomes.
- 표본수 (n) 615
APA
Christopher CN, Evenson KR, et al. (2025). Association of Self-Reported Walking Pace With Cancer Incidence and Mortality: The Women's Health Accelerometry Collaboration.. Journal of physical activity & health, 22(12), 1549-1556. https://doi.org/10.1123/jpah.2024-0839
MLA
Christopher CN, et al.. "Association of Self-Reported Walking Pace With Cancer Incidence and Mortality: The Women's Health Accelerometry Collaboration.." Journal of physical activity & health, vol. 22, no. 12, 2025, pp. 1549-1556.
PMID
40835222 ↗
Abstract 한글 요약
[BACKGROUND] While the health benefits of walking are well-established, it is not clear if walking pace is associated with cancer-related outcomes.
[PURPOSE] To investigate associations of self-reported walking pace with cancer incidence and mortality among women 62-99 years of age in the Women's Health Accelerometry Collaboration.
[METHODS] Women self-reported walking pace, classified as brisk (≥3 mph), average (2-2.9 mph), casual (<2 mph), or does not walk regularly, and were followed for cancer outcomes. Multivariable stratified Cox proportional hazards models estimated hazard ratios and 95% confidence intervals.
[RESULTS] There were 22,358 women in the analytic sample. During a mean 8.0 years of follow-up, 1891 women developed cancer (n = 615 cancer deaths). Self-reported walking paces were not associated with all site cancer incidence (compared with a brisk walking pace: average walking pace hazard ratio, 1.08 (95% confidence interval, 0.95-1.23); casual walking pace, 1.15 (0.97-1.33), and does not walk regularly 1.14 (0.97-1.34) nor cancer mortality (average walking pace, 0.97 [0.76-1.25], casual walking pace, 0.98 [0.74-1.30], and does not walk regularly 1.20 [0.90-1.60]). Findings were similar when colon, endometrial, and lung cancer were examined, separately. However, casual walking pace was associated with a higher risk of a composite of inactivity-related cancers (1.21 [1.00-1.47]), and breast cancer (1.40 [1.09-1.80]) compared with a brisk walking pace.
[CONCLUSIONS] Slower, compared with faster, self-reported walking paces may be related to a higher risk of some cancers in postmenopausal women. Future research is needed to confirm these findings and investigate mechanisms underlying the associations of walking pace with these cancers.
[PURPOSE] To investigate associations of self-reported walking pace with cancer incidence and mortality among women 62-99 years of age in the Women's Health Accelerometry Collaboration.
[METHODS] Women self-reported walking pace, classified as brisk (≥3 mph), average (2-2.9 mph), casual (<2 mph), or does not walk regularly, and were followed for cancer outcomes. Multivariable stratified Cox proportional hazards models estimated hazard ratios and 95% confidence intervals.
[RESULTS] There were 22,358 women in the analytic sample. During a mean 8.0 years of follow-up, 1891 women developed cancer (n = 615 cancer deaths). Self-reported walking paces were not associated with all site cancer incidence (compared with a brisk walking pace: average walking pace hazard ratio, 1.08 (95% confidence interval, 0.95-1.23); casual walking pace, 1.15 (0.97-1.33), and does not walk regularly 1.14 (0.97-1.34) nor cancer mortality (average walking pace, 0.97 [0.76-1.25], casual walking pace, 0.98 [0.74-1.30], and does not walk regularly 1.20 [0.90-1.60]). Findings were similar when colon, endometrial, and lung cancer were examined, separately. However, casual walking pace was associated with a higher risk of a composite of inactivity-related cancers (1.21 [1.00-1.47]), and breast cancer (1.40 [1.09-1.80]) compared with a brisk walking pace.
[CONCLUSIONS] Slower, compared with faster, self-reported walking paces may be related to a higher risk of some cancers in postmenopausal women. Future research is needed to confirm these findings and investigate mechanisms underlying the associations of walking pace with these cancers.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.